BioCardia, Inc. (BCDA) Ownership
BCDA ownership summary
as of October 18, 2026- Institutions
- 14.8% of shares outstanding
- Insiders
- 17.92% of shares outstanding
- Shares outstanding
- 15.1M
- Float
- 12.3M shares available to trade
- Short interest
- 4.66% 619K shares short
- Days to cover
- 1.83 short interest down 28.3% vs prior month
- Institutions 14.78%
- Insiders 17.92%
- Other investors 67.30%
BCDA top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Citigroup Inc | 2.63% | 398K | $365,786 | +397,594 (0.0%) | June 30, 2026 |
| 2 | CM Management, LLC | 1.98% | 300K | $276,000 | +170,000 (+130.8%) | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 0.82% | 125K | $114,624 | — | June 30, 2026 |
| 4 | Pingora Partners LLC | 0.80% | 120K | $110,751 | +84,643 (+236.8%) | June 30, 2026 |
| 5 | UBS Group AG | 0.51% | 78K | $71,409 | +77,619 (0.0%) | June 30, 2026 |
| 6 | Geode Capital Management, LLC | 0.44% | 67K | $61,331 | −27,623 (−29.3%) | June 30, 2026 |
| 7 | Vanguard Fiduciary Trust Co | 0.44% | 66K | $60,968 | — | June 30, 2026 |
| 8 | Susquehanna International Group, LLP | 0.26% | 39K | $35,704 | −18 (−0.0%) | June 30, 2026 |
| 9 | Brown Advisory Holdings Inc | 0.23% | 36K | $32,695 | — | June 30, 2026 |
| 10 | Commonwealth Equity Services, LLC | 0.15% | 23K | $21,512 | +5,100 (+27.9%) | June 30, 2026 |
| 11 | Citadel Advisors Llc | 0.15% | 23K | $21,120 | −40,428 (−63.8%) | June 30, 2026 |
| 12 | StoneX Group Inc | 0.13% | 20K | $18,418 | +20,020 (0.0%) | June 30, 2026 |
| 13 | Wealth Enhancement Advisory Services, LLC | 0.12% | 18K | $17,020 | +18,500 (0.0%) | June 30, 2026 |
| 14 | GSA Capital Partners LLP | 0.09% | 13K | $11,833 | +12,862 (0.0%) | June 30, 2026 |
| 15 | Tower Research Capital LLC | 0.02% | 3,187 | $2,932 | +209 (+7.0%) | June 30, 2026 |
| 16 | Morgan Stanley - Brokerage Accounts | 0.02% | 3,105 | $2,857 | — | June 30, 2026 |
| 17 | Allied Private Wealth LLC | 0.01% | 1,449 | $1,333 | +1,449 (0.0%) | June 30, 2026 |
| 18 | Global Retirement Partners, LLC. | <0.01% | 411 | $378 | — | June 30, 2026 |
| 19 | SBI Securities Co Ltd | <0.01% | 9 | $8 | — | June 30, 2026 |
| 20 | Advisor Group Holdings, Inc. | 0.00% | 1 | $1 | — | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 788K shares and 3 cut 68K.
BCDA top mutual fund and ETF holders
5 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Abante Quant Value FI | 0.48% | 73K | $66,740 | +33,667 (+86.6%) | August 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.39% | 58K | $53,657 | +11,846 (+25.5%) | August 31, 2026 |
| 3 | Vanguard MStar Total Stk Mkt Idx Invest | 0.37% | 56K | $51,123 | — | August 31, 2026 |
| 4 | Fidelity Series Total Market Index | 0.07% | 11K | $9,684 | — | August 31, 2026 |
| 5 | Fidelity Total Market Index | 0.02% | 3,237 | $2,978 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
BCDA insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-21 | Peter Altman | Buy | $1.23 | 400 | $492 |
| 2026-04-20 | Peter Altman | Buy | $1.23 | 600 | $738 |
| 2026-02-04 | Peter Altman | Buy | $1.13 | 5,000 | $5,650 |
| 2026-01-21 | Peter Altman | Buy | $1.34 | 300 | $402 |
| 2026-01-20 | Peter Altman | Buy | $1.32 | 600 | $792 |
| 2025-12-17 | Peter Altman | Buy | $1.30 | 900 | $1,170 |
| 2025-12-16 | Peter Altman | Buy | $1.37 | 200 | $274 |
| 2025-09-19 | Andrew Scott Blank | Buy | $1.25 | 288,000 | $360,000 |
| 2025-09-19 | Peter Altman | Buy | $1.25 | 48,000 | $60,000 |
| 2025-09-19 | Simon H Stertzer | Buy | $1.25 | 398,400 | $498,000 |
| 2025-08-22 | Peter Altman | Buy | $1.83 | 700 | $1,281 |
| 2025-08-13 | Peter Altman | Buy | $1.83 | 100 | $183 |
| 2025-08-12 | Peter Altman | Buy | $1.75 | 400 | $700 |
| 2025-08-11 | Peter Altman | Buy | $1.76 | 1,700 | $2,992 |
| 2025-06-30 | Andrew Scott Blank | Buy | $2.08 | 72,289 | $150,361 |
| 2025-06-30 | David Mcclung | Buy | $2.08 | 4,819 | $10,024 |
| 2025-06-30 | Peter Altman | Buy | $2.08 | 24,096 | $50,120 |
| 2025-06-30 | Simon H Stertzer | Buy | $2.08 | 72,289 | $150,361 |
| 2025-05-30 | Peter Altman | Buy | $2.21 | 100 | $221 |
| 2025-05-22 | Peter Altman | Buy | $1.89 | 700 | $1,323 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
BCDA shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns BCDA
Institutional investors own 14.8% of BioCardia's shares and insiders 17.92%. The largest holder is Citigroup Inc with 2.63% of the shares (398K), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 3 reduced their stake in the latest filings. Short interest is 4.66% of the float, or 1.83 days of average trading volume. The share count rose 100,419.6% since 2014.
Related: BCDA analyst forecast, BCDA key metrics. See the BCDA stock overview for the latest quote and news.
BCDA ownership FAQ
Who owns the most BioCardia stock?
The largest shareholders of BioCardia are Citigroup Inc (2.63%), CM Management, LLC (1.98%), Vanguard Capital Management, LLC (0.82%), Pingora Partners LLC (0.80%), UBS Group AG (0.51%).
What percentage of BioCardia is owned by institutions?
Institutions hold 14.8% of BioCardia's shares outstanding; insiders hold 17.92%.
Which funds own BioCardia?
The largest fund holders of BioCardia are Abante Quant Value FI (0.48%), Fidelity Extended Market Index (0.39%), Vanguard MStar Total Stk Mkt Idx Invest (0.37%), Fidelity Series Total Market Index (0.07%), Fidelity Total Market Index (0.02%).
What is BioCardia's short interest?
619K shares of BioCardia were sold short, 4.66% of the float; at the average daily volume it would take 1.83 days to cover.
Are insiders buying or selling BioCardia?
Of the latest 20 reported insider transactions in BioCardia (since May 22, 2025), 20 were purchases and 0 were sales.
How many shares of BioCardia are outstanding?
BioCardia has 15.1M shares outstanding, of which 12.3M are in the public float.